Best Peptides for Longevity: Epitalon vs MOTS-c vs NAD+ vs SS-31

Short Answer: Match the Buy to the Research Target

Epitalon is the clearest fit for telomere and telomerase research. MOTS-c fits mitochondrial signaling, glucose handling, metabolic stress, and exercise response. NAD+ fits cellular-energy cofactor research, although NAD+ is a coenzyme, not a peptide. SS-31 fits cardiolipin, inner-mitochondrial-membrane organization, electron transport, and ATP biology.

No controlled human head-to-head trial ranks all four, and none has proved human lifespan extension. A change in biological age or one biomarker is not the same as a longevity outcome.

The buying sequence is straightforward: choose the research lane, compare the compound-specific evidence, check live price per mg, verify the current lot through vendor profiles and PeptidePub methodology, then apply a confirmed offer from current deals before checkout.

Epitalon vs MOTS-c vs NAD+ vs SS-31 at a Glance

Track the outcome that matches the lane. Telomere length, glucose markers, cardiorespiratory fitness, and functional performance answer different questions. Cross-compound price per mg also does not compare potency or value. Use it to compare vendors selling the same compound.

What the Epitalon Evidence Shows

Epitalon has the most direct telomere story in this group. PMID 12937682 reported induced telomerase activity and telomere elongation in human somatic cells.

A newer cell study, PMID 40908429, treated 21NT and BT474 cells with 0.1, 0.2, 0.5, or 1.0 mcg/mL daily for 4 days. In 21NT cells, telomeres increased from 2.4 kb to 4 kb at 0.5 and 1.0 mcg/mL, while hTERT rose 12-fold at 1.0 mcg/mL. BT474 telomeres peaked at 8 kb with 0.2 mcg/mL, and hTERT rose fivefold at 0.5 mcg/mL.

Normal IBR.3 and HMEC cells received 1.0 mcg/mL daily for 3 weeks. Telomerase activity rose fourfold in IBR.3 and 26-fold in HMEC.

Those are specific, interesting signals, but they are cell findings. They do not show that Epitalon extends human lifespan. For buyers pursuing the telomere lane, exact AEDG identity matters. Start with the Epitalon guide, compare live Epitalon prices, and use the Epitalon buyer guide for a deeper purchase check.

What the MOTS-c and NAD+ Evidence Shows

PMID 33473109 studied 10 healthy young men. Acute exercise increased skeletal-muscle MOTS-c 11.9-fold. Circulating MOTS-c rose 1.6-fold during exercise and 1.5-fold after exercise, then moved toward baseline after 4 hours. This supports a human exercise-response signal. The intervention and performance experiments were in mice, so they should not be presented as proof of a human longevity outcome.

MOTS-c is the cleaner purchase when the question centers on mitochondrial signaling, AMPK, glucose handling, or metabolic stress. Review the MOTS-c guide, live prices, and buyer guide.

For NAD+, PMID 31278280 was an 8-week randomized, double-blind, placebo-controlled oral nicotinamide riboside trial. Whole-blood NAD+ increased about 22%, 51%, and 142% at 100, 300, and 1,000 mg/day. That shows precursor target engagement, not direct injectable or IV NAD+ equivalence and not lifespan extension.

NAD+ still occupies a distinct cellular-energy cofactor lane. Check the NAD+ guide, live NAD+ prices, and the format buyer guide. Confirm the product is NAD+, not NR, NMN, NADH, or nicotinamide.

What the SS-31 Evidence Shows

SS-31, elamipretide, and MTP-131 refer to the same mitochondria-targeting tetrapeptide in the literature. It binds cardiolipin and is studied for inner-mitochondrial-membrane organization, electron transport, and ATP biology.

PMID 29500292 was a randomized dose-escalation study in primary mitochondrial myopathy. It reported Class I evidence of improved 6-minute walk distance. PMID 32096613 was a randomized crossover trial assessing 6-minute walk performance, fatigue, functional outcomes, and safety. These human studies give SS-31 the deepest defined drug-development history of the four options, but the populations were disease-specific. Keep those results separate from healthy longevity claims.

The FDA granted accelerated approval to Forzinity, elamipretide injection, on September 19, 2025 for Barth syndrome in patients weighing at least 30 kg. That validates a defined prescription formulation and indication. It does not make every research vial labeled SS-31 equivalent to Forzinity.

For cardiolipin and mitochondrial-membrane research, use the SS-31 guide, compare live SS-31 prices, and review the 2026 cost guide.

Current Epitalon and MOTS-c Price Per Mg

This is a September 9, 2026 snapshot. Stock, code eligibility, shipping, taxes, and prices can change.

Epitalon

• Double R 50 mg: $79.99 list, $67.99 after 15% PEPTIDEPUB, or $1.36/mg. Kovera Labs, 7/7 testing fields.
• Valor 50 mg: $80.99 after 10%, or $1.62/mg. AccumarkLabs, 5/7.
• Ascension 10 mg: $25 after 50%, or $2.50/mg. Kovera Labs, 6/7.

MOTS-c

• Peptide Society 40 mg: $69.99 list, $55.99 after 20% PEPTIDEPUB, or $1.40/mg. IS-Lab, 4/7.
• Atomik 40 mg: $84.15 after 15% PEPTIDEPUB15, or $2.10/mg. Kovera Labs, 6/7.
• Double R 10 mg: $29.74 after 15%, or $2.97/mg. 7/7.

Double R leads this Epitalon comparison on both normalized price and testing depth. Peptide Society leads MOTS-c on price, while Double R shows broader testing coverage. Compare current offers on the Epitalon and MOTS-c pages. Use the cost-per-dose tool to compare the offers that are actually in stock.

Current NAD+ and SS-31 Price Per Mg

NAD+

• Ascension 1,000 mg: $104 list, $52 after 50% PEPTIDEPUB, or $0.052/mg. Kovera Labs, 6/7.
• Valor 1,000 mg: $94.49 after 10%, or about $0.094/mg. AccumarkLabs, 5/7.
• Peptide Society 500 mg: $55.99 after 20%, or about $0.112/mg. IS-Lab, 4/7.

SS-31

• Double R 50 mg: $139.99 list, $118.99 after 15% PEPTIDEPUB, or $2.38/mg. Kovera Labs, 7/7.
• Valkyrie 50 mg: $166.50 after 10%, or $3.33/mg. Horizon Analytical, 3/7.
• Atomik 50 mg: $169.15 after 15%, or $3.38/mg. Kovera Labs, 6/7.
• Ascension 10 mg: $39.99 after 50%, or $4.00/mg. Kovera Labs, 6/7.

Ascension leads the current NAD+ market on price per mg. Double R leads this SS-31 group on both price and seven-field coverage. Compare the live NAD+ page and live SS-31 page immediately before checkout.

Do not use the much lower NAD+ price per mg to declare it a better longevity buy than a peptide. Molecular identity, research target, quantity, and potency differ. Price per mg is most useful within a compound.

COA and Vendor Checks Before Buying

Require a current matching batch, named independent laboratory, report date, direct verification path, LC-MS or equivalent identity, HPLC or UPLC purity, and quantitative net content.

PeptidePub scores seven fields: net content, purity, identification, heavy metals, sterility, endotoxins, and contaminant screening. A vendor-level 7/7 or 6/7 score is useful context, not proof for the exact vial in your cart.

Apply the identity check compound by compound:

• Epitalon should state AEDG or the exact Epitalon identity.
• MOTS-c should match the exact 16-amino-acid identity.
• NAD+ should state NAD+, its salt form, and oxidized-state clarity. It should not be NR, NMN, NADH, or nicotinamide.
• SS-31 should state SS-31 or elamipretide. Do not infer Forzinity equivalence.

A 99% purity result alone does not prove correct identity, labeled milligrams, sterility, endotoxin status, or a current-lot match. Use the practical COA guide, vendor directory, and methodology together. Once identity, current-lot proof, and value align, the verified Bodybuilding Health route is available.

Match the Buy to a Biological-Age Tracking Plan

Choose Epitalon for telomere biology, MOTS-c for metabolic signaling and exercise response, NAD+ for cellular-energy cofactor research, and SS-31 for cardiolipin and mitochondrial membranes.

Establish a baseline first. Repeat the same measurement method and use the same laboratory when possible. Epigenetic clocks, pace-of-aging scores, telomere length, fasting glucose, insulin, HbA1c, lipids, blood pressure, cardiorespiratory fitness, strength, and function are separate measures. Do not collapse them into one claim that aging slowed.

Change one major research variable at a time so the result stays interpretable. That is measurement discipline, not a dosing protocol. No controlled human trial shows that stacking all four improves biological age.

FAQ

What is the best peptide for longevity?

There is no universal winner. Epitalon best matches telomere research, MOTS-c metabolic signaling, and SS-31 mitochondrial-membrane research. NAD+ matches cellular-energy cofactor research but is not a peptide.

Which option has the strongest human evidence?

SS-31 has randomized disease-specific human studies and an approved formulation for Barth syndrome. Oral NAD+ precursor trials show human target engagement. Epitalon and native MOTS-c buyer claims lean more heavily on cells, animals, and small human biomarker studies.

Which is cheapest?

Within each current market, after-code leaders are Epitalon at $1.36/mg, MOTS-c at $1.40/mg, NAD+ at $0.052/mg, and SS-31 at $2.38/mg. Do not compare those raw per-mg figures across unlike compounds.

Can a biological-age test prove a peptide is working?

No single score proves causation or lifespan extension. Repeat the same method and interpret it beside conventional metabolic, cardiovascular, and functional measures.

Can these four be stacked?

No controlled human trial proves the four-compound combination. Buy the option that matches the primary research question and avoid hiding the result behind several simultaneous changes.

Bottom Line

Epitalon is the direct buy for telomere and telomerase research. MOTS-c is the direct buy for mitochondrial signaling, glucose handling, and exercise response. NAD+ is the cellular-energy cofactor buy. SS-31 is the cardiolipin and mitochondrial-membrane buy, with the deepest disease-specific human development history in this comparison.

Use this checkout sequence:

1. Define the primary research target.
2. Compare the evidence maturity.
3. Inspect the exact identity and current-lot COA.
4. Compare live price per mg within that compound.
5. Check vendor testing, apply a confirmed offer from deals, and compare delivered cost.

The live compound pages for Epitalon, MOTS-c, NAD+, and SS-31 keep the decision tied to current stock and codes.

Do not buy a peptide without checking PeptidePub first.